These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 25874924)

  • 1. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
    Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
    Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
    Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
    Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the Antimicrobial Activity of Tilapia Piscidin 3 (TP3) and TP4 and Their Effects on Immune Functions in Hybrid Tilapia (Oreochromis spp.).
    Pan CY; Tsai TY; Su BC; Hui CF; Chen JY
    PLoS One; 2017; 12(1):e0169678. PubMed ID: 28085905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
    Dinc G; Demiraslan H; Elmali F; Ahmed SS; Metan G; Alp E; Doganay M
    Chemotherapy; 2013; 59(5):325-9. PubMed ID: 24525528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
    Meletis G; Oustas E; Botziori C; Kakasi E; Koteli A
    New Microbiol; 2015 Jul; 38(3):417-21. PubMed ID: 26147150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrotransfer of the tilapia piscidin 3 and tilapia piscidin 4 genes into skeletal muscle enhances the antibacterial and immunomodulatory functions of Oreochromis niloticus.
    Lin WC; Chang HY; Chen JY
    Fish Shellfish Immunol; 2016 Mar; 50():200-9. PubMed ID: 26828260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
    Clock SA; Tabibi S; Alba L; Kubin CJ; Whittier S; Saiman L
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):343-6. PubMed ID: 23601454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.
    Karakonstantis S; Kritsotakis EI; Gikas A
    Infection; 2020 Dec; 48(6):835-851. PubMed ID: 32875545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms?
    Shankar C; Nabarro LEB; Anandan S; Veeraraghavan B
    Microb Drug Resist; 2017 Jun; 23(4):437-446. PubMed ID: 27564414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.
    Cunha BA
    J Clin Microbiol; 2009 May; 47(5):1613. PubMed ID: 19403778
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
    Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
    Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
    Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
    Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
    Bandy A; Almaeen AH
    PLoS One; 2020; 15(6):e0233704. PubMed ID: 32516308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.
    Wu G; Wu P; Xue X; Yan X; Liu S; Zhang C; Shen Z; Xi T
    Peptides; 2013 Jul; 45():73-7. PubMed ID: 23643614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.